CAS: 15128-82-2; 2-Nitropyridin-3-Ol

该化合物是一种硝酸pyridine衍生物,在3位置有氢氧基组,作为有机合成的多功能中间体.其结构将电子脱色(硝酸)和电子施食(氢氧)组结合起来,使药品,农用化学品和协调化学能够有选择地发挥作用.该化合物的再活性有利于核生殖替代和金属复合化,使其对构建热循环框架很有价值.在标准条件下,该物质具有中等稳定性,在极有机溶剂中具有溶解性.其应用包括将其用作催化剂系统中生物活性分子和离心剂的前体.适当的处理由于对热和强氧化剂的潜在敏感度而建议.HPLC和NMR等分析方法证实了纯度和结构完整性.

结构式图片

相似化合物

16867-03-1 20265-37-6 15128-89-9

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号74037-50-6 3-乙氧基-2-硝基吡啶 | CAS号109-00-2 3-羟基吡啶 | CAS号1111637-77-4 3-(二氟甲氧基)-2-硝基吡啶 | CAS号106840-72-6 ethyl N-(3-hydr... | CAS号337463-88-4 L-4-氰基苯丙氨酸 | CAS号39968-33-7 1-羟基-7-偶氮苯并三氮唑(HOAt) | CAS号152170-29-1 噻唑并[4,5-b]吡啶-2(3H)-酮 | CAS号443956-08-9 6-溴-2-硝基吡啶-3-醇 | CAS号209530-92-7 1-AZETIDINECARB... | CAS号74037-50-6 3-乙氧基-2-硝基吡啶 | CAS号52092-47-4 2-硝基-5-氯吡啶 | CAS号6636-78-8 2-氯-3-羟基吡啶

合成工艺路线路线简述

    3-羟基吡啶置于aluminium Trinitrate体系中,用 乙腈 用作溶剂,以60%的收率获得3-羟基-2-硝基吡啶
    参考文献:碘(III)通过非布朗斯台德酸性no 2 +生成的苯酚亲电硝化
    标题:碘(III)通过非布朗斯台德酸性no 2 +生成的苯酚亲电硝化
    摘要:使用碘基苯作为基于碘(III)和硝酸铝作为硝基基团来源的有机催化剂,开发了用于苯酚亲电硝化的第一个催化程序.该原子经济方案发生在温和的,非布朗斯台德酸性和开放式烧瓶反应条件下,具有宽泛的官能团耐受性,包括多个杂环.(smd:Mecn)mo8-Hx /(lanlo8 + F,6-311 + G *)水平的密度泛函理论(dft)计算表明反应通过阳离子途径进行,该途径有效地产生了no 2 +离子,从而是中性条件下的硝化物种.
    Doi:10.1021/acs.Orglett.8B04141

    海关参考信息

    专利信息


    专利号:US-7465842-B2
    优先权日:2004-08-26
    标 题 :Enantioselective biotransformation for preparation of protein tyrosine kinase inhibitor intermediates
    发明人:KUNG PEI-PEI; MARTINEZ CARLOS; TAO JUNHUA
    权利人:AGOURON PHARMA
    摘要:The invention relates to biocatalytic methods for preparing enantiomerically pure stereoisomers of 1-(2,6-dichloro-3-fluorophenyl)ethanol. Disclosed are methods of preparation of the desired (S)-enantiomer, which methods are based on a combination of enzymatic resolution, chemical esterification and chemical hydrolysis with inversion of 1-(2,6-dichloro-3-fluorophenyl)ethyl esters or stereoselective bio-reduction of 2,6-dichloro-3-fluoro-acetophenone with a biocatalyst such as an enzyme or a microorganism. The chiral (S)-enantiomer can be used in the synthesis of certain enantiomerically enriched, ether linked 2-aminopyridine compounds that potently inhibit auto-phosphorylation of human heptocyte growth factor receptor.

    专利号:US-9919064-B2
    优先权日:2012-08-10
    标 题 :Compositions, methods, and systems for the synthesis and use of imaging agents
    发明人:CESATI RICHARD R; RADEKE HEIKE S; PANDEY SURESH K; PUROHIT AJAY; ROBINSON SIMON P
    权利人:LANTHEUS MEDICAL IMAGING INC
    摘要:The present invention provides compounds with imaging moieties for imaging a subject. The present invention also relates to systems, compositions, and methods for the synthesis and use of imaging agents, or precursors thereof. An imaging agent precursor may be converted to an imaging agent using the methods described herein. In some cases, a composition or plurality of imaging agents is enriched in 18 F. In some cases, an imaging agent may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.

    专利号:US-11401277-B2
    优先权日:2017-11-29
    标 题 :Anti-bacterial heterocyclic compounds and their synthesis
    发明人:PEER MOHAMED SHAHUL HAMEED; BHARATHAM NAGAKUMAR; KATAGIHALLIMATH NAINESH; SHARMA SREEVALLI; NANDISHAIAH RADHA; RAMACHANDRAN VASANTHI
    权利人:BUGWORKS RES INC
    摘要:The invention relates to compounds of Formula I and Formula (B) along with their stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms, and pharmaceutically active derivatives thereof. These compounds are useful for killing or inhibiting the growth of a microorganism selected from the group consisting of bacteria, virus, fungi, and protozoa.

    专利号:US-11229713-B2
    优先权日:2014-11-25
    标题:Methods and compositions for 18F-radiolabeling of biologics
    发明人:DONNELLY DAVID
    权利人:BRISTOL MYERS SQUIBB CO
    摘要:The invention relates to water soluble 18 F-prosthetic groups and the synthesis and use of 18 F-labeled biological molecules containing the 18 F-prosthetic groups for imaging various processes within the body, for detecting the location of molecules associated with disease pathology, and for monitoring disease progression are disclosed.

    专利号:CN-112125841-A
    优先权日:2020-10-23
    标题:A new method for the synthesis of crizotinib intermediates

    专利号:US-4552967-A
    优先权日:1984-01-12
    标 题:Process for the synthesis of intermediates in the preparation of diaminopyridines
    发明人:GREENE JAMES M; LAVAGNINO EDWARD R; PIKE ANDREW J; TAYLOR EDWARD C
    权利人:LILLY CO ELI
    摘要:The present invention relates to a process for preparing aminonitropyridines comprising reacting an alkoxynitropyridine with ammonium acetate.
    上海艾拜克国际贸易有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.shanghai-apex.com
    电话: 021-50931877👤
    📞上海艾拜克国际贸易有限公司 ⚠️参考联系方式

    销售电话:021-50931877
    邮箱:sales@shanghai-apex.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: S L Gwaltney Nd, Et Al. Novel Sulfonate Derivatives: Potent Antimitotic Agents. Bioorg Med Chem Lett. 2001 Jul 9;11(13):1671-3.

    合成参考文献


    摘要:U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals., NX#04089
    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2014).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知